Boston's life sciences cluster was built on the promise that if you earned a doctorate and came to Kendall Square, the jobs ...

It’s the latest move in the race by drug companies to corner more of the highly lucrative obesity drug market.

Poplar Therapeutics Inc. launched on Wednesday capitalized with $50 million Series A financing and led by Chip Baird, the ...

The U.S. excels at funding discovery and celebrating breakthroughs, then neglects the hard work of manufacturing them at ...

As they prepare for the J.P. Morgan Healthcare Conference next week, biotech leaders and analysts say companies are better ...

Heading into the 2026 J.P. Morgan Healthcare Conference, industry watchers are expecting the rise of China, the quantifiable ...

With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...

Boston has everything you’d want in a biotech hub: smart talent, leading academic institutions, commercial infrastructure, and a wavering-but-still-flowing stream of venture capital. That unique mix ...

Dr. Margulis has more than 25 years of science and business development experience in the Life Science industry and is currently a Chief Operating Officer at Mansfield Bio-Incubator, building an ...

Dan McGrath oversees the leasing and asset management of Berkeley’s overall investment portfolio. In this capacity, he develops and implements strategies to add value to the portfolio, manages all ...

A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...